Bumetanide and Eprex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide (bumetanide) and Eprex (epoetin alfa). Common drug interactions include immunosuppressant drug level increased among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Eprex. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Eprex?

Eprex has active ingredients of epoetin alfa. eHealthMe is studying from 5,554 Eprex users. Check the latest studies of Eprex.

On Jul, 13, 2026

34 people who take Bumetanide and Eprex together, and have interactions are studied.

What are the common drug interactions of Bumetanide and Eprex, by gender? *:

female:

Immunosuppressant drug level increased
Renal impairment (severely reduced kidney function)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac failure congestive
Pericardial effusion (fluid around the heart)
Coma (state of unconsciousness lasting more than six hours)
Conjunctival haemorrhage (bleeding underneath the conjunctiva)
Drug administration error
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

male:

Drug ineffective
Red cell aplasia (a type of anaemia affecting the precursors to red blood cells)
Intra-abdominal haemangioma (intra-abdominal non-cancerous tumour)
Renal failure chronic (long lasting kidney dysfunction)
Abdominal distension
Blood creatinine increased
Complement factor c3 decreased
Cough
Decreased appetite
Diarrhoea

What are the common drug interactions of Bumetanide and Eprex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal distension
Anaemia (lack of blood)
Blood creatinine increased
Blood potassium increased
Complement factor c3 decreased
Cough
Decreased appetite
Diarrhoea
Drug ineffective
Eyelid oedema (eyelids are swollen and contain excessive fluid)

30-39:

n/a

40-49:

Coma (state of unconsciousness lasting more than six hours)
Mouth haemorrhage (bleeding from mouth)
Neutropenia (an abnormally low number of neutrophils)
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Thrombocytopaenic purpura (a bleeding disorder in which the immune system destroys platelets)
Thrombocytopenic purpura (a bleeding disorder in which the immune system destroys platelets)
White blood cell count decreased

50-59:

n/a

60+:

Drug ineffective
Immunosuppressant drug level increased
General physical health deterioration (weak health status)
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
Intra-abdominal haemangioma (intra-abdominal non-cancerous tumour)
Pericardial effusion (fluid around the heart)
Renal failure chronic (long lasting kidney dysfunction)
Activated partial thromboplastin time shortened
Acute hepatic failure
Acute respiratory distress syndrome

What are the existing conditions these people have? *

Lower Respiratory Tract Infection: 7 people, 20.59%
Right Ventricular Failure (right half of the heart fails to work): 2 people, 5.88%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 5.88%
Chronic Renal Failure (kidney failure): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Eprex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously